Abiomed announces q4 fy 2020 revenue of $207 million and 28.1% operating margin

Abiomed announces q4 fy 2020 revenue of $207 million and 28.1% operating margin.q4 gaap earnings per share $0.70.q4 revenue $207 million versus refinitiv ibes estimate of $207.2 million.q4 earnings per share estimate $0.94 -- refinitiv ibes data.will not be providing full year 2021 revenue or operating margin guidance at this time.will analyze and monitor this dynamic environment and will provide an update on guidance when appropriate.company is taking proactive actions to mitigate business impact of covid-19 to better match expenses to revenue in q1.hold on hiring, eliminating non-critical consultants, contractors, and temporary workers.reducing discretionary spending and implementing alternate work schedules for aachen and danvers production teams.ceo and coo have reduced their salaries by 100%, vps and directors have reduced their salaries by 50% and 20% respectively for q1.board of directors have also reduced their cash retainers by 50% for q1.non-director employees at massachusetts and german headquarters will be taking a minimum of one-week furlough or unused vacation.field team will work on monthly operating plans to allow for flexibility and potential to increase sequentially each week.
ABMD Ratings Summary
ABMD Quant Ranking